Pelvic High Grade Chondrosarcoma Delayed Development: Can Bisphosphonates be Responsible? A Case Report

Case Report

Austin Oncol.2016; 1(3): 1012.

Pelvic High Grade Chondrosarcoma Delayed Development: Can Bisphosphonates be Responsible? A Case Report

Raimondo P¹, Tiziana R², Alessandra L³, Pietro P¹, Giovanni G4, Alessandro C5 and Boffano M¹

¹Department of Oncologic and Reconstructive Orthopaedic, AOU Città della Salute e della Scienza CTO Hospital Torino, Via Zuretti, Italy

²Department of Radiology, AOU Città della Salute e della Scienza CTO Hospital Torino, Via Zuretti, Italy

³Department of Pathology, AOU Città della Salute e della Scienza - OIRM-S.Anna Hospital Torino, Italy

4Department of Oncology, IRCCS Candiolo, Italy

5Department of Oncology, Gradenigo Hospital, Italy

*Corresponding author: Michele Boffano, Dept Oncologic and Reconstructive Orthopaedic- AOU Città della Salute e della Scienza di Torino – Via Zuretti, Torino, Italy

Received: September 11, 2016; Accepted: November 08, 2016; Published: November 09, 2016

Abstract

High grade Chondrosarcoma (CS) is a surgical disease despite its aggressive behaviour of recurring locally and spreading to the lungs; at Imaging, amorphous snowflake calcification in the lytic area and extraosseous calcified mass are characteristic. Conventional chemo-radiotherapy is ineffective. Some preliminary in vitro studies showed that Nitrogen-containing BisPhosphonates (N-BPs) may play a role in the treatment of CS. We report on a 83-year-old man patient diagnosed in June 2012 with high grade CS of the left pelvis. At Imaging abundant reactive sclerosing bone with small well delimitated lytic areas, not typical of high grade CS, and the typical large calcified mass spreading into the pelvis were present. In the last 10 years he was treated with N-BPs weekly for fragility vertebral fractures. X-rays of the pelvis were periodically performed: in 1990 in the left pubic ramus two small spot calcifications were evident; in 2002 a sclerotic and lytic lesion of the left pubic ramus was present, hyper camp tant at whole body bone scintigraphy; in 2003 the pubic lesion was more lytic, and extended to acetabulum. In absence of symptoms, no other imaging was performed until 2012. We hypothesise that N-BPs influenced in vivo the development of the sarcoma, at imaging present at least from 2002, inhibiting the bone resorption, inducing bone sclerosing and controlling pain for many years. This case suggest that N-BPS may play a role in vivo in controlling the development of CS and pain. Further research is needed.

Keywords: Chondrosarcoma; BisPhosphonates; X-rays

Introduction

Chondrosarcoma (CS) is the second most frequent malignant bone tumour in adults; it is characterised by the production of malignant cartilaginous tissues with lobular type architecture. The conventional intramedullary or central CS is the most frequent type, and it most commonly involves the long bones or pelvis in up to 65% of cases [1]. Hyaline cartilage nodules have a high water content and peripheral enchondral ossification. At Imaging, CS appears translucent at X-rays, hypodense at Computed Tomography (CT) scan, hypointense at T1 sequences and hyperintense at T2 weighted and fat suppressed Magnetic Resonance (MR) sequences: the typical lobular endosteal scalloping and the distinctive ring-andarc calcification with progressive cortical destruction and extension in contiguous soft tissue are evident. The cortex responds leading to cortical remodelling and thickening, less frequently periosteal reaction, but not to a diffuse reactive bone sclerosis [2,3]. Although high grade CS is considered to be at high risk for metastases, usually CS is treated by en bloc surgical resection with wide margins because it does not respond to conventional chemotherapy or to radiotherapy. Surgical adequate margins are difficult to be obtained when CS develops in the pelvic girdle because often the CS has a large size and connections with articular, nervous, vascular and visceral structures; disability is often the final result [4]. Nitrogen-containing BisPhosphonates (N-BPs) are currently approved for the treatment of bone metastases independently of the primary tumour type: they are able to change the bone and tumour microenvironment, delaying (or reducing) the ability of malignancy to emerge [5,6]. Some preliminary studies in vitro and in vivo suggest that N-BPs might be able to inhibit growth of primary bone tumours [7-10] in particular CS [11-13] and to decrease pain in vivo [14]. We report on a 83-yearold male patient diagnosed in June 2012 with high grade CS of the left pelvis: at Imaging, abundant reactive sclerosing bone with small well delimitated lytic areas, not typical of high grade CS, and the typical large calcified mass spreading into the pelvis, were present. He was treated for 10 years with N-BPs weekly for fragility vertebral fractures and primary hyperparathyroidism. We hypothesise that N-BPs influenced in vivo the development of the sarcoma, at imaging present at least from 2002, inhibiting the bone resorption, inducing bone sclerosing and controlling pain for many years, allowing a high quality of life until the last 3 months.

Care Presentation

In June 2012 an 83-year-old Caucasian male, with persisting pain at the left side of the groin and thigh from 3 months, was sent for diagnosis and staging to a Regional Referral Centre for Bone and Soft Tissue Sarcomas. X-Rays (Figure 1a) and CT scan (Figure 1b,1c) showed, in the left pubic ramus, acetabulum and iliac bone (area 1, 2 and 3 according to Musculoskeletal Tumour Society) abundant reactive bone and limited cortical mottled destruction, well delimited by sclerotic bone; and a large mass with arc-and-ring calcifications arising from the pubic ramus protruding into the pelvis. MRI (Figure 1d,1e,1f,1g) demonstrated a typical lobular lesion extending into contiguous soft tissue. After a contrast-enhanced Ultrasound (CEUS) study, a core needle biopsy focused on the more anarchic vascularised area, as a potential source of a representative pathological tissue (Figure 1h) [15]. Histology demonstrated chondrosarcoma GIII; at general staging, absence of metastatic lesions. The patient refused any surgical treatment and a palliative therapy was started. At history, the patient referred recurrent chronic aspecific lower back pain irradiating to the left leg. In 1990 (the patient was 61 years old) an X-ray of the pelvis demonstrated two small spot calcifications in the left pubic bone (Figure 2). In July 2002 (72 years old) an X-ray showed a limited irregular sclerotic and lytic lesion in the left pubis and acetabulum, with endosteal scalloping and a lobular pattern of translucency (Figure 3); the lesion was hypercaptant at whole body bone scintigraphy. Diagnosis of primary hyperparathyroidism (pHPT), Monoclonal Gammopathy of Undetermined Significance (MGUS) and fragility fracture of L4 and L5 was advanced; after evaluation of osteoporosis by posteroanterior lumbar and bilateral hip Dual Energy X-Ray Absorptiometry (DXA), therapy with alendronate 10mg/die (replaced in 2007 with risedronate 75 mg/ a week), Calcium and Vitamin D3 was started; periodical clinical and blood controls were performed in the following years. In 2003, epidural corticosteroids injection for lumbar discal protrusion in narrow canal solved an acute pain; at X-ray the endosteal scalloping at pubic ramus was more evident, while the lesion appeared more sclerotic in the acetabulum (Figure 4); in absence of symptoms, no further Imaging was performed. From March 2012 pain at the left side of the groin and anterior thigh occurred; in May 2012 risedronate was confirmed and, due to worsening of left hip pain, Imaging, reported at the beginning of the history, was performed.